Scott Long

Array ( [id] => 6100864 [patent_doc_number] => 20110004953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Method Of Identifying A Compound For Preventing And/Or Treating An Autoimmune Disease' [patent_app_type] => utility [patent_app_number] => 12/749593 [patent_app_country] => US [patent_app_date] => 2010-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10632 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20110004953.pdf [firstpage_image] =>[orig_patent_app_number] => 12749593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087731 [patent_doc_number] => 20110217239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'SYSTEM AND METHOD OF EVALUATING A PROTEIN OF INTEREST ON TUMOR GROWTH INHIBITION WHILE FOLLOWING THE TUMOR IN VIVO OR IN VITRO' [patent_app_type] => utility [patent_app_number] => 12/717143 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7018 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217239.pdf [firstpage_image] =>[orig_patent_app_number] => 12717143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286504 [patent_doc_number] => 08642834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation' [patent_app_type] => utility [patent_app_number] => 12/660443 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 35376 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12660443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426697 [patent_doc_number] => 20100151576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS' [patent_app_type] => utility [patent_app_number] => 12/708866 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18392 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151576.pdf [firstpage_image] =>[orig_patent_app_number] => 12708866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772420 [patent_doc_number] => 08426376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Angiogenesis inhibitor' [patent_app_type] => utility [patent_app_number] => 12/702272 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16249 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12702272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138469 [patent_doc_number] => 20120093786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'TREATMENT OF LIMB ISCHEMIA' [patent_app_type] => utility [patent_app_number] => 13/141453 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7041 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093786.pdf [firstpage_image] =>[orig_patent_app_number] => 13141453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589388 [patent_doc_number] => 20100235927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'NON-HUMAN ANIMAL MODEL FOR LUNG CARCINOMA' [patent_app_type] => utility [patent_app_number] => 12/695645 [patent_app_country] => US [patent_app_date] => 2010-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7203 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20100235927.pdf [firstpage_image] =>[orig_patent_app_number] => 12695645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503030 [patent_doc_number] => 08741340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Cell lines and their use in encapsulated cell biodelivery' [patent_app_type] => utility [patent_app_number] => 13/145669 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 19134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9126620 [patent_doc_number] => 08574565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-05 [patent_title] => 'Pharmaceutical composition to protect an animal against a disorder arising from an infection with a bacterium that belongs to the group of nocardioform actinomycetes' [patent_app_type] => utility [patent_app_number] => 13/144042 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13888 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13144042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153649 [patent_doc_number] => 08586556 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules' [patent_app_type] => utility [patent_app_number] => 12/643909 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 14602 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12643909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543205 [patent_doc_number] => 08318494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Genetic material and chromosomal processing and manipulation methods' [patent_app_type] => utility [patent_app_number] => 12/622427 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3045 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12622427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6001565 [patent_doc_number] => 20110117521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'BIOLOGICAL REGENERATE' [patent_app_type] => utility [patent_app_number] => 12/622108 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6749 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117521.pdf [firstpage_image] =>[orig_patent_app_number] => 12622108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964608 [patent_doc_number] => 09012218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Differentiation of human embryonic stem cells' [patent_app_type] => utility [patent_app_number] => 12/603889 [patent_app_country] => US [patent_app_date] => 2009-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 4 [patent_no_of_words] => 11272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12603889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510154 [patent_doc_number] => 20110256213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'PHOSPHOLIPID MICELLAR AND LIPOSOMAL COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/124605 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24517 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256213.pdf [firstpage_image] =>[orig_patent_app_number] => 13124605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6351579 [patent_doc_number] => 20100021924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Transgenic animal and methods for decreasing cardiac cell death via cardiac-specific sir2alpha overexpression' [patent_app_type] => utility [patent_app_number] => 12/575021 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9989 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021924.pdf [firstpage_image] =>[orig_patent_app_number] => 12575021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9625957 [patent_doc_number] => 08795632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Disease animal model for chronic pain' [patent_app_type] => utility [patent_app_number] => 13/001743 [patent_app_country] => US [patent_app_date] => 2009-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 11555 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441074 [patent_doc_number] => 20100104540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS' [patent_app_type] => utility [patent_app_number] => 12/570871 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23419 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104540.pdf [firstpage_image] =>[orig_patent_app_number] => 12570871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464509 [patent_doc_number] => 20090324709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'LIPOSOMAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/554216 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7985 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324709.pdf [firstpage_image] =>[orig_patent_app_number] => 12554216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087778 [patent_doc_number] => 20110217263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'EXPANSION OF HAEMOPOIETIC PRECURSORS' [patent_app_type] => utility [patent_app_number] => 13/061693 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8350 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217263.pdf [firstpage_image] =>[orig_patent_app_number] => 13061693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6295157 [patent_doc_number] => 20100160208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 12/585086 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21629 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160208.pdf [firstpage_image] =>[orig_patent_app_number] => 12585086 [rel_patent_id] =>[rel_patent_doc_number] =>)